-
Mashup Score: 4HRQOL instruments for clinical trials in AL amyloidosis | PROM - 12 month(s) ago
Summarizing the methods, findings, and recommendations of the health-related quality of life instruments for clinical trials in AL amyloidosis. Read more
Source: www.dovepress.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 3
In this ARC Talks Webinar, Dr. Morie Gertz will give a 101 overview of clinical trials, including consideration in how they are designed, and the phases needed for drug development. Dr. Gertz will also discuss the current clinical trials that are evaluating the next generation of drugs for the treatment of AL and ATTR amyloidosis. Join us if you would like to learn more about the essentials of…
Source: ZoomCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
📅May 25 1-2PM ET At this month's #ARCTALKS webinar, Dr. @MorieGertz will give a 101 overview of #ClinicalTrials for #amyloidosis and discuss the current trials that are evaluating the next generation of drugs for the treatment of #AL and # #ATTR: https://t.co/XNbOmykTzY https://t.co/Fx6JextQRK
-
-
Mashup Score: 0
Photo: No known restrictions on publication. @Batchelorshow 1/2: #ClassicRogoway: Rise of the Robots: Warplanes vs war drones vs AI; Tyler Rogoway, @thewarzone, @thedrive (First posted May…
Source: The Podcast AppCategories: Healthcare Professionals, Latest HeadlinesTweet-
Rise of the Robots: Warplanes vs war #drones vs #Al Tyler Rogoway, @thewarzone, @thedrive @batchelorshow https://t.co/R21HSLH84O
-
-
Mashup Score: 1Researchers Improve AI Models Used in Drug Discovery » Discovery's EdgeDiscovery's Edge - 2 year(s) ago
New Computational Benchmark Helps the Design and Selection of Drug Discovery Al Models Drug repurposing to expand treatment options for […]
Source: https://discoverysedge.mayo.eduCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
A new computational benchmark helps the design and selection of drug discovery #Al models: https://t.co/erC03Av4e8 https://t.co/GU6qB54D45
-
-
Mashup Score: 3The Age of AI, Crypto, and Web3 — with Kevin Roose - The Prof G Pod with Scott Galloway - 2 year(s) ago
Kevin Roose, a tech columnist at The New York Times, joins Scott to discuss the broader implications and opportunities of crypto and Web3. We also learn why Kevin is bullish on artificial intelligence, despite the negative externalities that may arise as the world moves towards automation. Follow Kevin on Twitter, @kevinroose. Scott opens with his thoughts on Apple launching a VR/AR…
Source: The Podcast AppCategories: Healthcare Professionals, Latest HeadlinesTweet-
The Age of #Al, #Crypto, and #Web3 - with @KevinRoose and @profgalloway Give it a listen: https://t.co/KeMMgIZ2b4
-
-
Mashup Score: 8
This survey study describes the results of a nationally representative survey on artificial intelligence use in health care delivery.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
Our study 'Perspectives of Patients About Artificial Intelligence in Health Care’ @JAMANetworkOpen - most people are optimistic about the future of #AL in medicine, but concerned about #privacy. @SanjayAnejaMD @DhruvKhullar @yuan_lu1 @YaleMed @WeillCornell https://t.co/cm8VTRykKv https://t.co/Pja3tj1QGq
-
-
Mashup Score: 10
AbstractBackground. Heart involvement represents the most ominous prognostic factor in light-chain amyloidosis (AL), often foreclosing curative therapies such a
Source: OUP AcademicCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Light-chain amyloidosis #AL: a case report of extraordinary sustained pathological response to cyclophosphamide, bortezomib, and dexamethasone combined therapy https://t.co/hMt58WSPet #EHJCaseReports @KardiologieHH @aayshacader @TJ_Yeo @ANazmiCalik @FarhanaAra https://t.co/lBdpebOZe0
-
-
Mashup Score: 2Jonathan Wall, PhD @univtennessee @utgsm @UTHSC_Cancer - 2 year(s) ago
Professor Jonathan Wall, Ph.D., Distinguished Professor and Director of the University of Tennessee Graduate School of Medicine’s Amyloidosis and Cancer
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Phase I/II Trial 124I-p5+14 Injection Safety Jonathan Wall, PhD @univtennessee @utgsm @UTHSC_Cancer #ASH21 #AL #ALAmyloidosis #Cancer #Research https://t.co/FRVjn6yzJM https://t.co/VS3aAMfTpG
-
-
Mashup Score: 2Podcast-Jonathan Wall, PhD @univtennessee @utgsm @UTHSC - 2 year(s) ago
Professor Jonathan Wall, Ph.D., Distinguished Professor and Director of the University of Tennessee Graduate School of Medicine’s Amyloidosis and Cancer
Source: www.oncologytube.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Podcast - Phase I/II Trial 124I-p5+14 Injection Safety Jonathan Wall, PhD @univtennessee @utgsm @UTHSC_Cancer #ASH21 #AL #ALAmyloidosis #Cancer #Research Link to Audio: https://t.co/bWEMy3Zvfg https://t.co/Qigx2Nd3JF
-
-
Mashup Score: 1Hurricanes - 3 year(s) ago
Emergency Preparedness If your child care program has any risk of being impacted by a hurricane, be sure you are prepared. All hurricanes, not only major ones, can cause considerable damage. If there is a chance you might be impacted by a hurricane, it should be included in your emergency plan, and you need to practice evacuation drills regularly. Sign up for emergency alerts, including alerts…
Source: Child Care Aware® of AmericaCategories: Latest Headlines, PediatricsTweet-
With millions of people in Mississippi and Louisiana without power due to #HurricaneIda, #childcare providers can take steps to address recovery issues, and communicate about any child care closures. https://t.co/gJyzQDpZX4 #hurricanes #emergencypreparedness #AL #FL #LA #MS #TX
-
The #AmyloidosisForum HRQOL Working Group identified existing #PRO instruments relevant across a broad spectrum of #AL #amyloidosis patients for use in clinical trials and practice to facilitate patient-focused drug development in AL amyloidosis: https://t.co/dhEC1TNx20 https://t.co/LftdQB2lfL